JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
CALL
Meta Platforms (Facebook)
META
$1.52T
| $37.9M | 0.01% |
442,129
+252,952
| +134% | +$20.7M |
|
1002
Broadridge
BR
$19.8B
| $37.7M | 0.01% |
753,623
+149,616
| +25% | +$7.97M |
|
|
KYNB
1003
Kyntra Bio
KYNB
$28.2M
| $37.7M | 0.01% |
64,133
+44,903
| +234% | +$26.1M |
|
|
AZPN
1004
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $37.6M | 0.01% |
826,500
-102,142
| -11% | -$4.65M |
|
|
IBKC
1005
DELISTED
IBERIABANK Corp
IBKC
| $37.6M | 0.01% |
551,434
-39,460
| -7% | -$2.58M |
|
|
AHL
1006
DELISTED
ASPEN Insurance Holding Limited
AHL
| $37.5M | 0.01% |
783,790
+22,372
| +3% | +$1.06M |
|
|
DYN
1007
DELISTED
Dynegy, Inc.
DYN
| $37.4M | 0.01% |
1,277,829
-1,272,866
| -50% | -$41.4M |
|
|
CSOD
1008
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $37.3M | 0.01% |
1,071,794
-35,085
| -3% | -$1.09M |
|
|
WPG
1009
DELISTED
Washington Prime Group Inc.
WPG
| $37.3M | 0.01% |
306,280
+39,515
| +15% | +$5.21M |
|
1010
Halozyme
HALO
$12.2B
| $37.3M | 0.01% |
1,649,750
-22,117
| -1% | -$389K |
|
1011
H&R Block
HRB
$5.82B
| $37.1M | 0.01% |
1,249,630
-1,332,608
| -52% | -$41.8M |
|
|
FLTX
1012
DELISTED
Fleetmatics Group PLC
FLTX
| $37M | 0.01% |
790,245
+10,887
| +1% | +$482K |
|
|
EV
1013
DELISTED
Eaton Vance Corp.
EV
| $37M | 0.01% |
944,720
+38,721
| +4% | +$1.6M |
|
1014
PUT
Williams Companies
WMB
$87.9B
| $36.9M | 0.01% |
642,400
-206,700
| -24% | -$10.6M |
|
|
OUTR
1015
DELISTED
OUTERWALL INC
OUTR
| $36.8M | 0.01% |
483,837
-161,095
| -25% | -$11.8M |
|
|
KYTH
1016
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $36.8M | 0.01% |
488,835
+324,289
| +197% | +$17.4M |
|
|
CCRN
1017
DELISTED
Cross Country Healthcare
CCRN
| $36.8M | 0.01% |
2,902,276
-329,322
| -10% | -$3.73M |
|
|
BBG
1018
DELISTED
Bill Barrett Corp
BBG
| $36.8M | 0.01% |
4,280,653
+1,794,032
| +72% | +$16.7M |
|
|
THOR
1019
DELISTED
THORATEC CORPORATION
THOR
| $36.7M | 0.01% |
822,322
-99,974
| -11% | -$4.38M |
|
|
RDS.A
1020
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $36.6M | 0.01% |
677,628
-286,689
| -30% | -$16.4M |
|
|
TYC
1021
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $36.6M | 0.01% |
907,594
-614,574
| -40% | -$26.2M |
|
1022
PUT
Petrobras Class A
PBR.A
$106B
| $36.5M | 0.01% |
4,474,800
-3,412,198
| -43% | -$28.6M |
|
1023
First Solar
FSLR
$25.7B
| $36.5M | 0.01% |
776,435
-40,747
| -5% | -$2.28M |
|
|
LINE
1024
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $36.4M | 0.01% |
4,079,702
+612,049
| +18% | +$7.16M |
|
|
PPL
1025
PPL Corp
PPL
$26.3B
| $35.9M | 0.01% |
1,218,768
-372,264
| -23% | -$11.6M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.